Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
Microsoft
MSFT
|
+$637M |
| 2 |
Apple
AAPL
|
+$587M |
| 3 |
Amazon
AMZN
|
+$559M |
| 4 |
AstraZeneca
AZN
|
+$329M |
| 5 |
Snowflake
SNOW
|
+$289M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$87.5M |
Sector Composition
| 1 | Technology | 25.04% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Hamilton Lane
HLNE
$6.5B
| $2.33M | ﹤0.01% |
27,504
+7,293
| +36% | +$619K |
|
1952
LeMaitre Vascular
LMAT
$2.1B
| $2.33M | ﹤0.01% |
43,801
+7,647
| +21% | +$406K |
|
1953
AngioDynamics
ANGO
$436M
| $2.32M | ﹤0.01% |
89,526
+7,967
| +10% | +$207K |
|
|
PENG
1954
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.4B
| $2.32M | ﹤0.01% |
104,060
+47,232
| +83% | +$1.05M |
|
|
ARR
1955
Armour Residential REIT
ARR
$1.69B
| $2.3M | ﹤0.01% |
42,571
+6,875
| +19% | +$371K |
|
1956
Lazard
LAZ
$5.16B
| $2.29M | ﹤0.01% |
50,100
-9,781
| -16% | -$448K |
|
1957
LendingTree
TREE
$1.01B
| $2.29M | ﹤0.01% |
16,376
+2,358
| +17% | +$330K |
|
1958
BJ's Restaurants
BJRI
$662M
| $2.29M | ﹤0.01% |
54,718
+4,653
| +9% | +$194K |
|
|
SWCH
1959
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $2.28M | ﹤0.01% |
89,920
+67,963
| +310% | +$1.73M |
|
1960
Agios Pharmaceuticals
AGIO
$2.2B
| $2.28M | ﹤0.01% |
49,353
+11,069
| +29% | +$511K |
|
1961
DNOW Inc
DNOW
$1.63B
| $2.28M | ﹤0.01% |
297,529
-39,748
| -12% | -$304K |
|
1962
Takeda Pharmaceutical
TAK
$47.9B
| $2.28M | ﹤0.01% |
138,985
| – | – |
|
1963
Gladstone Capital
GLAD
$519M
| $2.28M | ﹤0.01% |
100,526
-6,839
| -6% | -$155K |
|
|
NXGN
1964
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.27M | ﹤0.01% |
160,927
+13,221
| +9% | +$186K |
|
1965
Marten Transport
MRTN
$943M
| $2.27M | ﹤0.01% |
144,421
+16,707
| +13% | +$262K |
|
1966
BioCryst Pharmaceuticals
BCRX
$1.63B
| $2.26M | ﹤0.01% |
157,547
+111,484
| +242% | +$1.6M |
|
|
LDL
1967
DELISTED
Lydall, Inc.
LDL
| $2.26M | ﹤0.01% |
36,408
+1,456
| +4% | +$90.4K |
|
1968
Andersons Inc
ANDE
$1.37B
| $2.25M | ﹤0.01% |
72,931
-7,433
| -9% | -$229K |
|
|
ITCI
1969
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.25M | ﹤0.01% |
60,295
+13,492
| +29% | +$503K |
|
1970
CryoPort
CYRX
$453M
| $2.24M | ﹤0.01% |
33,702
+24,989
| +287% | +$1.66M |
|
|
RETA
1971
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.24M | ﹤0.01% |
22,253
+5,186
| +30% | +$522K |
|
1972
Designer Brands
DBI
$216M
| $2.24M | ﹤0.01% |
160,514
-30,964
| -16% | -$431K |
|
1973
Vanda Pharmaceuticals
VNDA
$264M
| $2.23M | ﹤0.01% |
130,322
+11,610
| +10% | +$199K |
|
1974
Heartland Express
HTLD
$670M
| $2.23M | ﹤0.01% |
139,363
+6,871
| +5% | +$110K |
|
1975
Schrodinger
SDGR
$1.43B
| $2.23M | ﹤0.01% |
40,776
+10,008
| +33% | +$547K |
|